Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02602314
Title Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia (SUSTRENIM)
Recruitment Active, not recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Gruppo Italiano Malattie EMatologiche dell'Adulto
Indications

chronic myeloid leukemia

Therapies

Imatinib

Nilotinib

Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.